The use of antifibrinolytic agents results in a reduction in transfused blood products during liver transplantation.
Ramsay
M A
MA
Department of Anesthesiology and Pain Management, Baylor University Medical Center, University of Texas Southwestern Medical School, Dallas 75246, USA.
D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D016913:Blood Component Transfusion; D005342:Fibrinolysis; D006488:Hemostasis, Surgical; D006801:Humans; D017093:Liver Failure / Q000503:physiopathology / Q000601:surgery; D016031:Liver Transplantation / Q000502:physiology; D013916:Thrombelastography; D014184:Transplantation, Homologous
D000933:Antifibrinolytic Agents